Effects of cotinine at cholinergic nicotinic receptors of the sympathetic superior cervical ganglion of the mouse

Toxicology

Volumn 144, Issue 1-3, 2000, Pages 99-105

  Schroff, K C ^a   Lovich, P ^a   Schmitz, O ^b   Aschhoff, S ^a   Richter, E ^a   Remien, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cotinine; Mouse; Nicotinic receptors; Sympathetic ganglion

Indexed keywords

COTININE; NICOTINE; NICOTINIC RECEPTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY ELECTROPHORESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG PURITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPERIOR CERVICAL GANGLION;

ANIMALS; COTININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, CAPILLARY; MEMBRANE POTENTIALS; MICE; NICOTINE; NICOTINIC AGONISTS; PERIPHERAL NERVOUS SYSTEM; RECEPTORS, NICOTINIC; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVOUS SYSTEM;

NICOTIANA TABACUM;

EID: 0034599540     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00195-X     Document Type: Article

References (35)

1. 14C]-labeled nicotine in the brain of mice and cats. Acta Physiol. Scand. 56:1962;249-257.
2. Balfour D.J.K., Benwell M.E.M. The role of brain dopamine systems in the psychopharmacological responses to nicotine. Asia Pac. J. Pharmacol. 8:1993;153-167.
3. Benowitz N.L. The use of biologic fluid samples in assessing tobacco smoke consumption. Grabowski J., Bell C.S. Measurement in the Analysis and Treatment of Smoking Behavior. 1983;6-26 NIDA, Washington, DC. NIDA Res. Monogr. 48.
4. Benowitz N.L., Jacob P. Metabolism of nicotine studied by a dual stable isotope method. Clin. Pharmacol. Ther. 56:1994;483-493.
5. Benowitz N.L., Kuyt F., Jacob P., Jones R.T., Osman A.-L. Cotinine disposition and effects. Clin. Pharmacol. Ther. 34:1983;604-611.
6. Benowitz N.L., Porchet H., Jacob P. Pharmacokinetics, metabolism and pharmacodynamics of nicotine. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. 1990;112-157 Oxford University Press, New York.
7. Benowitz N.L., Jacob P., Fong I., Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 268:1994;296-303.
8. Borzelleca J.F., Bowman E.R., McKennis H. Studies on the respiratory and cardiovascular effects of (-)-cotinine. J. Pharmacol. Exp. Ther. 221:1982;368-372.
9. Corrigal W.A., Franklin K.B.J., Coen K.M., Clarke P.B.S. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 107:1992;285-289.
10. Corrigal W.A., Coen K.M., Adamson K.L. Self administered nicotine activates the mesolimbic dopaminergic system through the ventral tegmental area. Brain Res. 653:1994;278-284.
11. Crooks P.A., Dwoskin L.P. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem. Pharmacol. 54:1997;743-753.
12. Crooks P.A., Li M., Dwoskin L.P. Determination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine. Drug Metab. Dispos. 23:1995;1175-1177.
13. Crooks P.A., Li M., Dwoskin L.P. Metabolites of nicotine in rat brain after peripheral nicotine administration: cotinine, nornicotine and norcotinine. Drug Metab. Dispos. 25:1997;47-54.
14. Deutsch J., Hegedus L., Greig N.H., Rapoport S.I., Soncrant T.T. Electron-impact and chemical ionization detection of nicotine and cotinine by gas chromatography-mass spectrometry in rat plasma and brain. J. Chromatogr. 579:1992;93-98.
15. 3H]dopamine release from rat striatal slices in a calcium-dependent manner. J. Pharmacol. Exp. Ther. 288:(3):1999;905-911.
16. Fibiger H.C., Phillips A.C. Role of catecholamine transmitters in brain reward systems: implications for the neurobiology of affect. Engel J., Oreland L. Brain Reward Systems and Abuse. 1987;61-74 Raven Press, New York.
17. Fuxe K., Everitt B.J., Hokfelt T. On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons. Pharmacol. Biochem. Behav. 10:1979;671-677.
18. Gorrod J.W., Jenner P. The metabolism of tobacco alkaloids. Hayes J. Essays in Toxicology 6. 1975;35-78 Academic Press, New York.
19. Gorrod J.W., Wahren J. Nicotine and Related Alkaloids: Absorption, Distribution, Metabolism, Excretion. 1993;Chapman and Hall, London.
20. Hatsukami D.K., Grillo M., Pentel P.R., Oncken C., Bliss R. Safety of cotinine in humans: physiologic, subjective, and cognitive effects. Pharmacol. Biochem. Behav. 57:1997;643-650.
21. Hatsukami D.K., Pentel P.R., Jensen J., Nelson D., Allen S.S., Goldman A., Rafael D. Cotinine: effects with and without nicotine. Psychopharmacology. 135:1998;141-150.
22. Herzig K.E., Callaway E., Halliday R., Naylor H., Benowitz N.L. Effects of cotinine on information processing in non-smokers. Psychopharmacology. 135:1998;127-132.
23. Hill P., Marquard H. Plasma and urine changes after smoking different brand of cigarettes. Clin. Pharmacol. Ther. 27:(5):1980;652-658.
24. 3H]dopamine release in rat striatum. J. Neurochem. 56:1991;603-610.
25. Kim K.S., Borzelleca J.F., Bowman E.R., McKennis H. Effects of some nicotine metabolites and related compounds on isolated smooth muscle. J. Pharmacol. Exp. Ther. 161:1968;59-69.
26. Langone J.J., Gijika H.B., van Vunakis H.V. Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry. 12:1973;5025-5030.
27. Petersen D.R., Norris K.J., Thompson J.A. A comparative study of the disposition of nicotine and its metabolites in three inbred mice strains. Drug Metab. Dispos. 12:1984;725-731.
28. Schlagmann C., Ulbrich H., Remien J. Bispyridinium (oxime) compounds antagonize the 'ganglion blocking' effect of pyridostigmine in isolated superior cervical ganglia of the rat. Arch. Toxicol. 64:1990;482-489.
29. Schmiterlöw C.G., Hansson E., Andersson G. Distribution of nicotine in central nervous system. Ann. N.Y. Acad. Sci. 142:1967;2-14.
30. Schroff K.-C., Aschhoff S., Remien J. Inhibitory effects of physostigmine and pyridostigmine at cholinergic receptors of the sympathetic superior cervical ganglion of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:(Suppl.):1998;R124.
31. Stalhandske T. Effects of increased liver metabolism of nicotine on its uptake, elimination and toxicity in mice. Acta Physiol. Scand. 80:1970;222-234.
32. Vainio P.J., Viluksela M., Tuominen R.K. Nicotine-like effects of cotinine on protein kinase C activity and noradrenal release in bovine adrenal chromatin cells. J. Autonom. Pharmacol. 18:1998;245-250.
33. Wilcox R.G., Hughes J., Roland J. Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br. Med. J. 2:1979;1026-1028.
34. Yamamoto K.-I., Domino E.F. Nicotine-induced EEG and behavioral arousal. Int. J. Neuropharmacol. 4:1965;359-373.
35. Zeidenberg P., Jaffe J.H., Kanzler M., Levitt M.D., Langone J.J., van Vunakis H.V. Nicotine: cotinine levels in blood during cessation of smoking. Comp. Psychiatry. 18:1977;93-101.